585
Views
15
CrossRef citations to date
0
Altmetric
Letter to the Editor

The Hazards of Period Specific and Weighted Hazard Ratios

ORCID Icon, , , , &
Pages 518-519 | Received 20 Mar 2020, Accepted 03 Apr 2020, Published online: 23 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Yuan-Li Shen, Sirisha Mushti, Flora Mulkey, Thomas Gwise, Xin Wang, Jiaxi Zhou, Xin Gao, Shenghui Tang, Marc R. Theoret, Richard Pazdur & Rajeshwari Sridhara. (2023) Rejoinder to Comments on “Non-Proportional Hazards – An Evaluation of the MaxCombo Test in Cancer Clinical Trials”. Statistics in Biopharmaceutical Research 15:2, pages 315-317.
Read now
Satrajit Roychoudhury, Keaven M Anderson, Jiabu Ye & Pralay Mukhopadhyay. (2023) Robust Design and Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working Group. Statistics in Biopharmaceutical Research 15:2, pages 280-294.
Read now
Zihan Lin, Dan Zhao, Junjing Lin, Ai Ni & Jianchang Lin. (2022) Statistical methods of indirect comparison with real-world data for survival endpoint under non-proportional hazards. Journal of Biopharmaceutical Statistics 32:4, pages 582-599.
Read now
Ray S. Lin, Ji Lin, Satrajit Roychoudhury, Keaven M. Anderson, Tianle Hu, Bo Huang, Larry F. Leon, Jason J. Z. Liao, Rong Liu, Xiaodong Luo, Pralay Mukhopadhyay, Rui Qin, Kay Tatsuoka, Xuejing Wang, Yang Wang, Jian Zhu, Tai-Tsang Chen & Renee Iacona. (2020) Rejoinder to Letter to the Editor “The Hazards of Period Specific and Weighted Hazard Ratios”. Statistics in Biopharmaceutical Research 12:4, pages 520-521.
Read now

Articles from other publishers (10)

Yi‐Cheng Tai, Weijing Wang & Martin T. Wells. (2023) Two‐sample inference procedures under nonproportional hazards . Pharmaceutical Statistics 22:6, pages 1016-1030.
Crossref
Alessandra Verzelloni Sef, Siân I Jaggar, Vladimir Trkulja, Rafael Alonso-Gonzalez, Davorin Sef & Marko I Turina. (2023) Factors associated with long-term outcomes in adult congenital heart disease patients with infective endocarditis: a 16-year tertiary single-centre experience. European Journal of Cardio-Thoracic Surgery 63:5.
Crossref
Michele Santacatterina. (2023) Robust weights that optimally balance confounders for estimating marginal hazard ratios. Statistical Methods in Medical Research 32:3, pages 524-538.
Crossref
Kim M. Jachno, Stephane Heritier, Robyn L. Woods, Suzanne Mahady, Andrew Chan, Andrew Tonkin, Anne Murray, John J. McNeil & Rory Wolfe. (2022) Examining evidence of time-dependent treatment effects: an illustration using regression methods. Trials 23:1.
Crossref
Kaihuan Qian & Xiaohua Zhou. (2022) Weighted Log-Rank Test for Clinical Trials with Delayed Treatment Effect Based on a Novel Hazard Function Family. Mathematics 10:15, pages 2573.
Crossref
Dominic Magirr & José L Jiménez. (2022) Design and analysis of group-sequential clinical trials based on a modestly weighted log-rank test in anticipation of a delayed separation of survival curves: A practical guidance. Clinical Trials 19:2, pages 201-210.
Crossref
Torben Martinussen. (2022) Causality and the Cox Regression Model. Annual Review of Statistics and Its Application 9:1, pages 249-259.
Crossref
José L. Jiménez, Julia Niewczas, Alexander Bore & Carl-Fredrik Burman. (2021) A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching. PLOS ONE 16:11, pages e0259178.
Crossref
Revathi Ananthakrishnan, Stephanie Green, Alessandro Previtali, Rong Liu, Daniel Li & Michael LaValley. (2021) Critical review of oncology clinical trial design under non-proportional hazards. Critical Reviews in Oncology/Hematology 162, pages 103350.
Crossref
Dominic Magirr. (2020) Non‐proportional hazards in immuno‐oncology: Is an old perspective needed?. Pharmaceutical Statistics 20:3, pages 512-527.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.